Bacil Pharma informs about quarterly statement on investor complaints

19 Oct 2016 Evaluate

Bacil Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Bacil Pharma Share Price

50.10 2.37 (4.97%)
01-Apr-2026 13:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.00
Dr. Reddys Lab 1223.40
Cipla 1196.80
Zydus Lifesciences 862.40
Lupin 2273.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×